Discover investment opportunities in 10 Cent Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in 10 Cent Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in 10 Cent Stocks using our Smart AI Filter.
6 stocks found for "10 Cent Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
2.11 | ±100.0% | -5.6 | 0.00% | |||
1.43 | ±100.0% | — | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
0.83 | ±61.9% | -3.1 | 0.00% | |||
1.25 | ±78.9% | -3.7 | 0.00% | |||
0.90 | ±50.6% | 161.0 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Nano Dimension Ltd (NASDAQ: NNDM) reported a fourth-quarter revenue increase of 282% Y/Y to $7.53 million from $1.97 million in 4Q20. The company attributed the revenue surge mainly to the consolidation of Essemtec, which it purchased in November 2021.
Read moreQ: What are the primary sectors represented by stocks on this screener page?
A: The screener displays stocks from various sectors including biotechnology (e.g., IMUX, IFRX), consumer goods (e.g., REED), and cannabis (e.g., TLRY). Investors may focus on biotechnology for innovation-driven growth or the rising cannabis market potential. However, sector-specific risks such as regulatory challenges should be considered.
Q: How does investing in biotechnology stocks like IMUX and IFRX appeal to growth-minded investors?
A: Biotechnology stocks like IMUX and IFRX offer significant growth potential due to their focus on innovative therapies. However, these investments may be volatile, as they are often contingent on successful drug trials and approvals. Investors should evaluate the pipeline and regulatory environment carefully.
Q: What income potential exists by investing in companies like TLRY?
A: Cannabis companies like TLRY rarely emphasize dividends, often prioritizing reinvestment for growth in the burgeoning cannabis market. While dividend income may be limited, the potential for capital appreciation exists if market share expands.
Q: Are any stocks on this screener page considered penny stocks, and what are the risks?
A: Stocks like FBLG and REED often trade at low prices, sometimes under one dollar, classifying them as penny stocks. These can offer significant upside but come with high risks, such as limited liquidity, higher volatility, and potential lack of extensive financial disclosures.
Q: How might stocks like NOTE and CNTX perform in different economic cycles?
A: Stocks like NOTE and CNTX could show varying performance across cycles. Tech and healthcare might offer resilience during downturns due to essential service demand, but they may face volatility due to innovation risk and operational changes. Investors must consider sector specifics and economic resilience.
Q: Do the stocks on this screener page provide any structural advantages?
A: Some stocks, like TLRY in the cannabis sector, may benefit from early industry entry, offering potential first-mover advantages. However, they may face challenges like regulatory hurdles or competitive scaling from new entrants. Investors should assess the company's market position and competitive landscape.